• No se han encontrado resultados

Non small cell lung cancer

Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer.

Trends in phase III randomized controlled clinical trials on the treatment of advanced non-small-cell lung cancer.

... different cancer- related pathways has led to the development of targeted therapies ...IV non- small- cell lung cancer ...

8

Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.

Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.

... Lung cancer represents the leading cause of cancer related death for both men and women, and even in early stages outcomes remain poor ...recurrent non-small cell lung ...

14

Systematic Review and Meta-Analysis of Randomized, Controlled Trials on Preoperative Physical Exercise Interventions in Patients with Non-Small-Cell Lung Cancer

Systematic Review and Meta-Analysis of Randomized, Controlled Trials on Preoperative Physical Exercise Interventions in Patients with Non-Small-Cell Lung Cancer

... Lung cancer (LC) is the leading cause of cancer death in both sexes, and is responsible for more than one-quarter (27%) of all cancer deaths ...new cancer cases and over one-quarter of ...

19

Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report.

Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation report.

... vanced non-small cell lung ...J Cancer. 2015; 51:317-26. 14. Spain. Estimated cancer prevalence, adult population: both se- ...National Lung Cancer Audit (LUCADA ...

12

Survival, classifications, and desmosomal plaque genes in non-small cell lung cancer.

Survival, classifications, and desmosomal plaque genes in non-small cell lung cancer.

... death. Lung cancer was estimated to account for 26% of all cancer deaths among females in ...(breast, lung and bronchus, and colorectum) in both sexes with the ex- ception of lung ...

8

Manejo quirrgico del cncer de pulmn  Hechos y algunas reflexiones

Manejo quirrgico del cncer de pulmn Hechos y algunas reflexiones

... 37.Lardinois D, Suter H, Hakki H, Rousson V, Betticher D, Ris HB. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus syste- matic sampling after complete resection for ...

5

Propuestas para la prevencin de cncer de pulmn en el sistema de salud en Mxico

Propuestas para la prevencin de cncer de pulmn en el sistema de salud en Mxico

... al. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of ...of non-small cell lung ...

5

Inmunoterapia en pacientes con cáncer de pulmón de células no pequeñas versus terapia convencional. Revisión sistemática

Inmunoterapia en pacientes con cáncer de pulmón de células no pequeñas versus terapia convencional. Revisión sistemática

... (Non- Small-cell lung cancer NSCLC) representa el 85% de todos los cánceres de pulmón y en un 40% es diagnosticado tardíamente y con los tratamientos disponibles actualmente (cirugía, ...

58

Radioterapia estereotáxica (SBRT) en el carcinoma no microcítico de pulmón (CNMP) localizado

Radioterapia estereotáxica (SBRT) en el carcinoma no microcítico de pulmón (CNMP) localizado

... stage non-small cell lung cancer (NSCLC), particularly for patients who are unable to tolerate surgical resection, and possibly as an alternative to surgery for some appropriately se- ...

6

Vol. 59, No. 2 (2020)

Vol. 59, No. 2 (2020)

... 19. Hoeijmakers F, Heineman DJ, Beck N, Klamer J, Tollenaar R, Wouters M, et al. Mediastinoscopy for Staging of Non-Small Cell Lung Cancer: Surgical Performance in The Netherlands. Ann ...

19

Factores que influyen en la demora diagnstica de la neoplasia de pulmn en egresados vivos

Factores que influyen en la demora diagnstica de la neoplasia de pulmn en egresados vivos

... Staging Non-small Cell Lung Cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice ...

7

Exactitud de la TC de Perfusión en comparación con la PET TC en el estudio de las Adenopatías Mediastínicas sospechosas de malignidad / tesis doctoral presentada por Manuel Modesto Alapont ; dirigida por Carlos Casillas Meléndez [y] Enrique Cases Viedma

Exactitud de la TC de Perfusión en comparación con la PET TC en el estudio de las Adenopatías Mediastínicas sospechosas de malignidad / tesis doctoral presentada por Manuel Modesto Alapont ; dirigida por Carlos Casillas Meléndez [y] Enrique Cases Viedma

... Real‐time endobronchial ultrasound‐guided transbronchial needle aspiration in mediastinal staging of non‐small cell lung cancer: how many aspirations per target lymph node station?. Ches[r] ...

245

Perfil mutacional por secuenciacin de nueva generacin en cncer de pulmn de clulas no pequeas en poblacin mexicana

Perfil mutacional por secuenciacin de nueva generacin en cncer de pulmn de clulas no pequeas en poblacin mexicana

... with non- small cell lung cancer ...90 lung adenocarcinomas and sequences were generated for a panel of 48 cancer ge- ...

10

2017.02.01.3

2017.02.01.3

... therapeutic cancer vaccine developed in Cuba and fully licensed in the country for use in adult patients with lung cancer non-small cell (NSCLC) in stage IIIB / ...

7

TítuloPreoperative pulmonary rehabilitation in lung cancer patients undergoing lung resection surgery

TítuloPreoperative pulmonary rehabilitation in lung cancer patients undergoing lung resection surgery

... 76 | P a g e such as COPD. The Stair Climb Test (SCT) has been successfully used as a surrogate for CPET in the preoperative evaluation of the lung resection candidate (Brunelli et al., 2013a). This inexpensive ...

344

Novel indole based tambjamine analogues induce apoptotic lung cancer cell death through p38 mitogen activated protein kinase activation

Novel indole based tambjamine analogues induce apoptotic lung cancer cell death through p38 mitogen activated protein kinase activation

... 9 antibodies, according to the manufacturer’s instructions. Antibodies were obtained from the following sources: anti-Caspase-3 (Cat#9662), anti-cleaved-Caspase-3 (Cat#9661), anti-Caspase-9 (Cat#9502), anti-PARP1 ...

37

Nuevos conceptos en el manejo de ventilacin unipulmonar

Nuevos conceptos en el manejo de ventilacin unipulmonar

... • CPAP non-ventilated lung • PEEP ventilated lung • HFPPV, partial vent1. • Selective pulmonary vasodilation.[r] ...

7

El rol de la esfingosina quinasa 1 y de la hemoxigenasa 1 en el cáncer

El rol de la esfingosina quinasa 1 y de la hemoxigenasa 1 en el cáncer

... Sunamura M, Duda DG, Ghattas MH, Lozonschi L, Motoi F, Yamauchi J, Matsuno S, Shibahara S, Abraham NG. 2003. Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer. Angiogenesis. 6 (1):15-24. ...

32

The novel anticancer drug hydroxytriolein inhibits lung cancer cell proliferation via a PKCα and ERK1/2 dependent mechanism

The novel anticancer drug hydroxytriolein inhibits lung cancer cell proliferation via a PKCα and ERK1/2 dependent mechanism

... of cancer but that it lacks therapeutic activity (Martin-Moreno, 2000; Stark and Madar, 2002; Fortes et ...of cancer cell arrest, differentiation, and death (Barceló-Coblijn et ...longer ...

12

Synthetic tambjamine analogues induce mitochondrial swelling and lysosomal dysfunction leading to autophagy blockade and necrotic cell death in lung cancer

Synthetic tambjamine analogues induce mitochondrial swelling and lysosomal dysfunction leading to autophagy blockade and necrotic cell death in lung cancer

... for lung cancer show very poor clinical outcomes, therefore, the development of novel anticancer agents with different mechanisms of action is urgently ...needed. Cancer cells have a reversed pH ...

27

Show all 6343 documents...

Related subjects